A new study has found that a recently approved drug for HIV produces fewer unpleasant side effects during the first three months of therapy than the standard treatment, according to published reports.
The Food and Drug Administration has approved a new single-pill treatment for HIV made by Gilead Sciences and Johnson & Johnson, Gilead said.
A generic drug maker has been granted approval from the Food and Drug Administration to manufacture its version of a urinary tract infection treatment.
Gilead Sciences has refiled an approval application with the Food and Drug Administration for an HIV drug, the drug maker said.
An investigational treatment for HIV made by Johnson & Johnson subsidiary Tibotec Pharmaceuticals works as...
Three new drugs for treating HIV from Gilead Sciences and J&J subsidiary Tibotec could have...